ARCHIVES

Kessler Promises Cancer Patient Liaison In FDA; Considers Joint Drugs, Biologics Oncology Review

This article is from The Cancer Letter archive.

Vol. 18 No. 33 | August 14, 1992

Download PDF Visit The Full Archive

Related Articles

Bertagnolli: Why Brigham Stopped Making Morcellation Available Outside Of A Registry Trial

July 4, 2014

FDA: Oncology Division Director Delap Promoted In Agency

May 29, 1998

Wyngaarden says NCI’s Special Authorities Are All Right With Him

May 14, 1982

Reimbursement: NCI, VA Begin Project On Clinical Trials Access For Veterans

January 17, 1997

Broder Says No Thanks To Acknowledgement For Paper’s Title

June 6, 1997

Breast Cancer: Working Group Sets Broad Agenda For Genetic Research

January 10, 1997